MilliporeSigma and Broad Institute Announce CRISPR License Framework to Encourage Innovation Read more
Sanofi : FDA to review isatuximab as a potential treatment for relapsed/refractory multiple myeloma Read more
Lynparza approved in Japan for 1st-line maintenance therapy in BRCA-mutated advanced ovarian cancer Read more
Gilead and Nurix Establish Strategic Collaboration to Develop Novel Therapies for Cancer and Other Diseases Read more
Boehringer and University of Dundee Highlight Successful PROTAC Drug Discovery Program and Extend Their Ongoing Anti-Cancer Alliance Read more
Bayer and Arvinas to Collaborate on Human PROTAC Therapies and Launch a Separate Joint Venture to Develop Agricultural PROTAC Applications Read more
Celgene and Acceleron Announce FDA Accepts Luspatercept Biologics License Application in Myelodysplastic Syndromes and Beta-Thalassemia Read more
Servier appoints Yposkesi for lentiviral vector GMP-manufacturing in CAR-T cell development technology Read more